Status | Study |
Completed |
Study Name: Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies. Condition: Pompe Disease Late-Onset Glycogen Storage Date: 2008-10-02 Interventions: Biological: Myozyme 30 mg/kg qow f and 40 mg/kg qow |
Completed |
Study Name: Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) Studies Condition: Pompe Disease Infantile-Onset Glycogen St Date: 2008-09-30 Interventions: Biological: Myozyme 10 mg/kg or 20 mg/kg qw OR 20 mg/kg or 40 mg/kg qow |
Completed |
Study Name: Newborn Screening Assay of Pompe's Disease Condition: Pompe Disease Date: 2008-07-09 Interventions: Other: Pompe disease newborn screening DBS will be tested for acid alpha-glucosidase (GAA)activity. Newb |
Recruiting |
Study Name: A Long Term Follow up Study in Late-onset Pompe Disease Condition: Pompe Disease Date: 2008-07-09 |
Recruiting |
Study Name: Muscle Response to Enzyme Replacement Therapy in Pompe Disease Condition: Pompe Disease Date: 2008-07-09 |
Completed |
Study Name: An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease Condition: Pompe Disease Glycogen Storage Disease Ty Date: 2008-06-17 Interventions: Biological: Alglucosidase Alfa |
Terminated |
Study Name: Study to Evaluate the Safety of AT2220 in Pompe Disease Condition: Pompe Disease Date: 2008-05-30 Interventions: Drug: AT2220 |
Completed |
Study Name: A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease Condition: Pompe Disease Glycogen Storage Disease Ty Date: 2007-08-10 Interventions: Other: Observation Ex vivo administration of AT2220 |
Recruiting |
Study Name: Pompe Disease Registry Condition: Glycogen Storage Disease Type II Pompe Di Date: 2005-09-30 |
Completed |
Study Name: Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 Condition: Glycogen Storage Disease Type II Date: 2005-08-01 Interventions: Biological: Myozyme 20 mg/kg qow or 40 mg/kg qow Oth |